Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

United Health Products (UEEC) Cash from Financing Activities (2016 - 2025)

United Health Products' Cash from Financing Activities history spans 15 years, with the latest figure at $600000.0 for Q4 2025.

  • Quarterly results put Cash from Financing Activities at $600000.0 for Q4 2025, up 95.73% from a year ago — trailing twelve months through Dec 2025 was $1.1 million (down 14.58% YoY), and the annual figure for FY2025 was $1.1 million, down 14.58%.
  • Cash from Financing Activities for Q4 2025 was $600000.0 at United Health Products, up from $193308.0 in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $600000.0 in Q4 2025 to a low of $92377.0 in Q3 2022.
  • The 5-year median for Cash from Financing Activities is $247372.0 (2022), against an average of $320664.5.
  • The sharpest move saw Cash from Financing Activities tumbled 72.01% in 2022, then soared 490.2% in 2023.
  • Year by year, Cash from Financing Activities stood at $238802.0 in 2021, then crashed by 43.42% to $135115.0 in 2022, then skyrocketed by 342.5% to $597881.0 in 2023, then crashed by 48.73% to $306538.0 in 2024, then skyrocketed by 95.73% to $600000.0 in 2025.
  • According to Business Quant data, Cash from Financing Activities over the past three periods came in at $600000.0, $193308.0, and $180000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.